CTD : Announces Home-Based Dosing of First Patient in US Extension Protocol of Clinical Trial using Intravenous Administration of Trappsol (R) Cyclo (TM) for Niemann-Pick Disease Type C

Press/Media: Press / Media

PeriodMay 23 2019

Media coverage

2

Media coverage

  • TitleCTD : Announces Home-Based Dosing of First Patient in US Extension Protocol of Clinical Trial using Intravenous Administration of Trappsol (R) Cyclo (TM) for Niemann-Pick Disease Type C
    Media name/outletMarketScreener.com
    CountryUnited States
    Date5/23/19
    PersonsDarius Adams
  • TitleCTD Holdings, Inc.: CTD Announces Home-Based Dosing of First Patient in US Extension Protocol of Clinical Trial using Intravenous Administration of Trappsol (R) Cyclo for Niemann-Pick Disease Type C
    Media name/outletFinanzNachrichten.de
    CountryGermany
    Date5/23/19
    PersonsDarius Adams